Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

25 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Chlorambucil Articles

Improved overall survival in most common leukemia treated with Roche’s MabThera

8 December 2009

Genmab plans to initiate four ofatumumab studies

1 September 2008

FDA clears Cephalon's Treanda for CLL

31 March 2008

Bayer's MabCampath cleared for CLL by EC

14 January 2008

CHMP advocates MabCampath approval

29 October 2007

FDA approves Campath as single agent for B-CLL

1 October 2007

Cephalon plans to file Treanda NDA in 3rd qtr

9 July 2007

Fludara cleared for first-line use in CLL

17 February 2003

M&I's MabCampath is approved by EMEA

12 July 2001

MabCampath nears EU approval for CLL

30 March 2001

Clinical Trial News In Brief

28 May 1998

LeukoSite Lead Product May Be On Market By 2000

28 May 1998

Sandoz MDR Drug Shows Promise In Early Trials

13 November 1995

COMPANIES HAVE SAY IN UK NHS DRUG ENQUIRY

14 February 1994

NOVEL TREATMENT FOR BREAST CANCER

2 November 1992

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS